RGLS Regulus Therapeutics | $1.55
-9.4% | 10/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.00 | Low | View details for HC Wainwright rating of Regulus Therapeutics (NASDAQ:RGLS) on 10/8/2024 |
UUUU Energy Fuels | $5.61
+3.9% | 10/8/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $10.50 -> $10.75 | High | View details for HC Wainwright rating of Energy Fuels (NYSE:UUUU) on 10/8/2024 |
SVRA Savara | $3.78
+1.1% | 10/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.00 | Low | View details for HC Wainwright rating of Savara (NASDAQ:SVRA) on 10/8/2024 |
AKBA Akebia Therapeutics | $1.32
| 10/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.50 -> $7.50 | Low | View details for HC Wainwright rating of Akebia Therapeutics (NASDAQ:AKBA) on 10/8/2024 |
SAVA Cassava Sciences | $26.05
+2.5% | 10/8/2024 | Upgraded by | HC Wainwright | Analyst V. Bernardino | Neutral -> Buy | $116.00 | High | View details for HC Wainwright rating of Cassava Sciences (NASDAQ:SAVA) on 10/8/2024 |
SRRK Scholar Rock | $29.49
-14.0% | 10/7/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $30.00 -> $35.00 | N/A | View details for HC Wainwright rating of Scholar Rock (NASDAQ:SRRK) on 10/7/2024 |
|
CLMT Calumet Specialty Products Partners | $20.26
-1.0% | 10/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $25.00 -> $25.00 | Low | View details for HC Wainwright rating of Calumet Specialty Products Partners (NASDAQ:CLMT) on 10/7/2024 |
ORKA Oruka Therapeutics | $27.51
+5.8% | 10/7/2024 | Initiated by | HC Wainwright | Analyst M. Kapoor | Buy | $45.00 | Low | View details for HC Wainwright rating of Oruka Therapeutics (NASDAQ:ORKA) on 10/7/2024 |
TYRA Tyra Biosciences | $21.64
+3.8% | 10/7/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $25.00 -> $30.00 | Medium | View details for HC Wainwright rating of Tyra Biosciences (NASDAQ:TYRA) on 10/7/2024 |
ENTX Entera Bio | $1.80
+0.6% | 10/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Entera Bio (NASDAQ:ENTX) on 10/7/2024 |
RYTM Rhythm Pharmaceuticals | $48.09
+1.9% | 10/7/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $64.00 -> $64.00 | High | View details for HC Wainwright rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 10/7/2024 |
BNTX BioNTech | $120.30
-1.0% | 10/7/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $113.00 -> $150.00 | Low | View details for HC Wainwright rating of BioNTech (NASDAQ:BNTX) on 10/7/2024 |
EU enCore Energy | $4.09
-1.4% | 10/7/2024 | Reiterated by | HC Wainwright | Analyst H. Ihle | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of enCore Energy (NASDAQ:EU) on 10/7/2024 |
KALV KalVista Pharmaceuticals | $11.21
-0.6% | 10/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 -> $20.00 | Low | View details for HC Wainwright rating of KalVista Pharmaceuticals (NASDAQ:KALV) on 10/7/2024 |
DMAC DiaMedica Therapeutics | $4.65
+6.4% | 10/7/2024 | Initiated by | HC Wainwright | Analyst M. Caufield | Buy | $7.00 | Medium | View details for HC Wainwright rating of DiaMedica Therapeutics (NASDAQ:DMAC) on 10/7/2024 |
ANGO AngioDynamics | $5.88
-3.6% | 10/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $14.00 -> $14.00 | Medium | View details for HC Wainwright rating of AngioDynamics (NASDAQ:ANGO) on 10/4/2024 |
HALO Halozyme Therapeutics | $54.13
+0.5% | 10/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $65.00 -> $65.00 | Medium | View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 10/4/2024 |
ETON Eton Pharmaceuticals | $7.40
+1.4% | 10/4/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $9.00 -> $11.00 | Low | View details for HC Wainwright rating of Eton Pharmaceuticals (NASDAQ:ETON) on 10/4/2024 |
SMMT Summit Therapeutics | $19.69
+4.1% | 10/4/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $45.00 -> $45.00 | High | View details for HC Wainwright rating of Summit Therapeutics (NASDAQ:SMMT) on 10/4/2024 |
IMMX Immix Biopharma | $1.53
+5.5% | 10/3/2024 | Reiterated by | HC Wainwright | Analyst R. Burns | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of Immix Biopharma (NASDAQ:IMMX) on 10/3/2024 |
BCTX BriaCell Therapeutics | $1.08
+0.9% | 10/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 -> $15.00 | Low | View details for HC Wainwright rating of BriaCell Therapeutics (NASDAQ:BCTX) on 10/3/2024 |
WKEY WISeKey International | $2.30
-0.4% | 10/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.00 -> $4.00 | Medium | View details for HC Wainwright rating of WISeKey International (NASDAQ:WKEY) on 10/3/2024 |
LXRX Lexicon Pharmaceuticals | $1.68
| 10/3/2024 | Reiterated by | HC Wainwright | Analyst J. Pantginis | Buy -> Buy | $10.00 -> $10.00 | Low | View details for HC Wainwright rating of Lexicon Pharmaceuticals (NASDAQ:LXRX) on 10/3/2024 |
EOLS Evolus | $16.50
+0.1% | 10/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $27.00 -> $27.00 | Medium | View details for HC Wainwright rating of Evolus (NASDAQ:EOLS) on 10/3/2024 |
ABOS Acumen Pharmaceuticals | $2.36
-0.8% | 10/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 -> $15.00 | High | View details for HC Wainwright rating of Acumen Pharmaceuticals (NASDAQ:ABOS) on 10/3/2024 |
URGN UroGen Pharma | $13.11
+5.6% | 10/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $60.00 -> $60.00 | Medium | View details for HC Wainwright rating of UroGen Pharma (NASDAQ:URGN) on 10/3/2024 |
SPRO Spero Therapeutics | $1.24
-4.6% | 10/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of Spero Therapeutics (NASDAQ:SPRO) on 10/3/2024 |
ATLX Atlas Lithium | $6.78
-5.6% | 10/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $41.00 -> $19.00 | Medium | View details for HC Wainwright rating of Atlas Lithium (NASDAQ:ATLX) on 10/3/2024 |
GNTA Genenta Science | $5.09
+5.8% | 10/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $25.00 -> $25.00 | High | View details for HC Wainwright rating of Genenta Science (NASDAQ:GNTA) on 10/2/2024 |
ESPR Esperion Therapeutics | $2.07
+1.5% | 10/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 -> $16.00 | High | View details for HC Wainwright rating of Esperion Therapeutics (NASDAQ:ESPR) on 10/2/2024 |
JOBY Joby Aviation | $5.67
-5.2% | 10/2/2024 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $9.00 -> $9.00 | High | View details for HC Wainwright rating of Joby Aviation (NYSE:JOBY) on 10/2/2024 |
PDSB PDS Biotechnology | $3.56
-4.6% | 10/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $21.00 -> $21.00 | High | View details for HC Wainwright rating of PDS Biotechnology (NASDAQ:PDSB) on 10/2/2024 |
FPAY FlexShopper | $1.33
+2.3% | 10/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.50 -> $2.50 | High | View details for HC Wainwright rating of FlexShopper (NASDAQ:FPAY) on 10/2/2024 |
PRME Prime Medicine | $3.78
+3.6% | 10/2/2024 | Reiterated by | HC Wainwright | Analyst A. He | Buy -> Buy | $10.00 -> $10.00 | Low | View details for HC Wainwright rating of Prime Medicine (NYSE:PRME) on 10/2/2024 |
KZR Kezar Life Sciences | $0.74
-3.9% | 10/2/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Neutral | | High | View details for HC Wainwright rating of Kezar Life Sciences (NASDAQ:KZR) on 10/2/2024 |
ADXN Addex Therapeutics | $10.30
+10.3% | 10/2/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $30.00 -> $30.00 | Low | View details for HC Wainwright rating of Addex Therapeutics (NASDAQ:ADXN) on 10/2/2024 |
PYPD PolyPid | $3.54
| 10/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $14.00 -> $14.00 | High | View details for HC Wainwright rating of PolyPid (NASDAQ:PYPD) on 10/2/2024 |
SGMT Sagimet Biosciences | $3.97
-4.8% | 10/2/2024 | Reiterated by | HC Wainwright | Analyst E. Arce | Buy -> Buy | $32.00 -> $32.00 | High | View details for HC Wainwright rating of Sagimet Biosciences (NASDAQ:SGMT) on 10/2/2024 |
LRMR Larimar Therapeutics | $7.09
+9.4% | 10/2/2024 | Initiated by | HC Wainwright | Analyst E. White | Buy | $15.00 | Medium | View details for HC Wainwright rating of Larimar Therapeutics (NASDAQ:LRMR) on 10/2/2024 |
GRTS Gritstone bio | $0.20
+5.2% | 10/1/2024 | Reiterated by | HC Wainwright | Analyst S. Lee | Buy -> Neutral | $4.00 -> $0.50 | High | View details for HC Wainwright rating of Gritstone bio (NASDAQ:GRTS) on 10/1/2024 |
[SHOCKING] Crypto Document Leak… (Ad) The crypto market waits for no one.
And my team of experts and I believe that a BIG move is right around the corner.
That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes. Download your digital copy now |
ELVN Enliven Therapeutics | $28.01
+2.0% | 10/1/2024 | Reiterated by | HC Wainwright | Analyst R. Burns | Buy -> Buy | $37.00 -> $37.00 | High | View details for HC Wainwright rating of Enliven Therapeutics (NASDAQ:ELVN) on 10/1/2024 |
PTN Palatin Technologies | $0.89
-2.2% | 10/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.00 -> $17.00 | N/A | View details for HC Wainwright rating of Palatin Technologies (NYSEAMERICAN:PTN) on 10/1/2024 |
ARCT Arcturus Therapeutics | $22.47
-5.9% | 10/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $63.00 -> $63.00 | High | View details for HC Wainwright rating of Arcturus Therapeutics (NASDAQ:ARCT) on 10/1/2024 |
STTK Shattuck Labs | $1.26
+11.5% | 10/1/2024 | Downgraded by | HC Wainwright | Analyst J. Pantginis | Buy -> Neutral | | High | View details for HC Wainwright rating of Shattuck Labs (NASDAQ:STTK) on 10/1/2024 |
AEYE AudioEye | $21.79
-4.6% | 10/1/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $23.00 -> $28.00 | High | View details for HC Wainwright rating of AudioEye (NASDAQ:AEYE) on 10/1/2024 |
RLYB Rallybio | $1.11
-1.8% | 10/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 -> $6.00 | High | View details for HC Wainwright rating of Rallybio (NASDAQ:RLYB) on 10/1/2024 |
AEON AEON Biopharma | $1.44
-4.0% | 10/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 -> $5.00 | Medium | View details for HC Wainwright rating of AEON Biopharma (NASDAQ:AEON) on 10/1/2024 |
PRTA Prothena | $16.69
+0.6% | 10/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $84.00 -> $84.00 | Low | View details for HC Wainwright rating of Prothena (NASDAQ:PRTA) on 10/1/2024 |
GANX Gain Therapeutics | $1.98
-7.0% | 10/1/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $8.00 -> $8.00 | Medium | View details for HC Wainwright rating of Gain Therapeutics (NASDAQ:GANX) on 10/1/2024 |
SVRA Savara | $3.78
+1.1% | 10/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Savara (NASDAQ:SVRA) on 10/1/2024 |
ANVS Annovis Bio | $8.31
+1.3% | 10/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 -> $30.00 | High | View details for HC Wainwright rating of Annovis Bio (NYSE:ANVS) on 10/1/2024 |
VRNA Verona Pharma | $31.77
-0.9% | 10/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $36.00 -> $36.00 | Medium | View details for HC Wainwright rating of Verona Pharma (NASDAQ:VRNA) on 10/1/2024 |
XENE Xenon Pharmaceuticals | $41.02
+1.1% | 10/1/2024 | Initiated by | HC Wainwright | Analyst D. Tsao | Buy | $53.00 | High | View details for HC Wainwright rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 10/1/2024 |
NMRA Neumora Therapeutics | $14.74
+1.2% | 10/1/2024 | Initiated by | HC Wainwright | Analyst D. Tsao | Buy | $30.00 | Medium | View details for HC Wainwright rating of Neumora Therapeutics (NASDAQ:NMRA) on 10/1/2024 |
ACET Adicet Bio | $1.43
+1.4% | 9/30/2024 | Reiterated by | HC Wainwright | Analyst E. White | Neutral | | High | View details for HC Wainwright rating of Adicet Bio (NASDAQ:ACET) on 9/30/2024 |
IMVT Immunovant | $29.61
+0.7% | 9/30/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $51.00 -> $51.00 | Medium | View details for HC Wainwright rating of Immunovant (NASDAQ:IMVT) on 9/30/2024 |
CYTK Cytokinetics | $54.33
-2.1% | 9/30/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $90.00 -> $90.00 | High | View details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 9/30/2024 |
ZVRA Zevra Therapeutics | $8.37
+7.4% | 9/30/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 -> $20.00 | Low | View details for HC Wainwright rating of Zevra Therapeutics (NASDAQ:ZVRA) on 9/30/2024 |
NYXH Nyxoah | $9.34
+0.4% | 9/30/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 -> $18.00 | Low | View details for HC Wainwright rating of Nyxoah (NASDAQ:NYXH) on 9/30/2024 |
LEGN Legend Biotech | $48.06
-3.1% | 9/30/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $73.00 -> $73.00 | Medium | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 9/30/2024 |
OVID Ovid Therapeutics | $1.10
-2.7% | 9/30/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $3.00 -> $3.00 | Low | View details for HC Wainwright rating of Ovid Therapeutics (NASDAQ:OVID) on 9/30/2024 |
BBIO BridgeBio Pharma | $24.73
-0.4% | 9/30/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $43.00 -> $43.00 | Low | View details for HC Wainwright rating of BridgeBio Pharma (NASDAQ:BBIO) on 9/30/2024 |
AQST Aquestive Therapeutics | $4.92
+1.4% | 9/30/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $9.00 -> $10.00 | High | View details for HC Wainwright rating of Aquestive Therapeutics (NASDAQ:AQST) on 9/30/2024 |
BLFS BioLife Solutions | $23.74
-0.9% | 9/30/2024 | Initiated by | HC Wainwright | Analyst Y. Chen | Buy | $29.00 | High | View details for HC Wainwright rating of BioLife Solutions (NASDAQ:BLFS) on 9/30/2024 |
BMEA Biomea Fusion | $11.40
+9.3% | 9/27/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $15.00 -> $40.00 | Medium | View details for HC Wainwright rating of Biomea Fusion (NASDAQ:BMEA) on 9/27/2024 |
LXRX Lexicon Pharmaceuticals | $1.68
| 9/27/2024 | Reiterated by | HC Wainwright | Analyst J. Pantginis | Buy -> Buy | $10.00 -> $10.00 | Low | View details for HC Wainwright rating of Lexicon Pharmaceuticals (NASDAQ:LXRX) on 9/27/2024 |
LUMO Lumos Pharma | $3.85
-0.3% | 9/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $28.00 -> $28.00 | Medium | View details for HC Wainwright rating of Lumos Pharma (NASDAQ:LUMO) on 9/27/2024 |
REE REE Automotive | $6.67
-7.6% | 9/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 -> $15.00 | High | View details for HC Wainwright rating of REE Automotive (NASDAQ:REE) on 9/27/2024 |
TVTX Travere Therapeutics | $15.21
-0.3% | 9/27/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $23.00 -> $18.00 | High | View details for HC Wainwright rating of Travere Therapeutics (NASDAQ:TVTX) on 9/27/2024 |
CRIS Curis | $5.01
-0.2% | 9/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $26.00 -> $26.00 | High | View details for HC Wainwright rating of Curis (NASDAQ:CRIS) on 9/27/2024 |
RZLT Rezolute | $4.78
| 9/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $14.00 -> $14.00 | Low | View details for HC Wainwright rating of Rezolute (NASDAQ:RZLT) on 9/27/2024 |
ENTX Entera Bio | $1.80
+0.6% | 9/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Entera Bio (NASDAQ:ENTX) on 9/27/2024 |
ATXS Astria Therapeutics | $11.21
-3.9% | 9/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 -> $16.00 | Medium | View details for HC Wainwright rating of Astria Therapeutics (NASDAQ:ATXS) on 9/27/2024 |
ENLV Enlivex Therapeutics | $1.50
-2.0% | 9/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 -> $6.00 | High | View details for HC Wainwright rating of Enlivex Therapeutics (NASDAQ:ENLV) on 9/27/2024 |
IVA Inventiva | $1.65
-2.4% | 9/26/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $22.00 -> $14.00 | High | View details for HC Wainwright rating of Inventiva (NASDAQ:IVA) on 9/26/2024 |
ACST Acasti Pharma | $3.05
-1.9% | 9/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | Low | View details for HC Wainwright rating of Acasti Pharma (NASDAQ:ACST) on 9/26/2024 |
EVAX Evaxion Biotech A/S | $2.84
-0.4% | 9/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $14.00 -> $14.00 | High | View details for HC Wainwright rating of Evaxion Biotech A/S (NASDAQ:EVAX) on 9/26/2024 |
PHAR Pharming Group | $8.71
+3.7% | 9/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $37.00 -> $37.00 | Low | View details for HC Wainwright rating of Pharming Group (NASDAQ:PHAR) on 9/26/2024 |
BRNS Barinthus Biotherapeutics | $1.21
-4.0% | 9/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 -> $5.00 | Low | View details for HC Wainwright rating of Barinthus Biotherapeutics (NASDAQ:BRNS) on 9/26/2024 |
CLDX Celldex Therapeutics | $30.55
+0.5% | 9/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $80.00 -> $80.00 | High | View details for HC Wainwright rating of Celldex Therapeutics (NASDAQ:CLDX) on 9/26/2024 |
DNTH Dianthus Therapeutics | $27.99
+5.7% | 9/26/2024 | Reiterated by | HC Wainwright | Analyst S. Ramakanth | Buy -> Buy | $40.00 -> $40.00 | Low | View details for HC Wainwright rating of Dianthus Therapeutics (NASDAQ:DNTH) on 9/26/2024 |
DRRX DURECT | $1.30
+2.4% | 9/26/2024 | Reiterated by | HC Wainwright | - | Neutral | | Low | View details for HC Wainwright rating of DURECT (NASDAQ:DRRX) on 9/26/2024 |
OPK OPKO Health | $1.47
+1.4% | 9/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 -> $3.00 | Low | View details for HC Wainwright rating of OPKO Health (NASDAQ:OPK) on 9/26/2024 |
BPMUF Basilea Pharmaceutica | $51.26
| 9/23/2024 | Upgraded by | HC Wainwright | Analyst R. Selvaraju | Strong-Buy | | Low | View details for HC Wainwright rating of Basilea Pharmaceutica (OTCMKTS:BPMUF) on 9/23/2024 |
IFRX InflaRx | $1.50
-2.0% | 9/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 -> $8.00 | Low | View details for HC Wainwright rating of InflaRx (NASDAQ:IFRX) on 9/25/2024 |
CLSK CleanSpark | $9.00
-1.1% | 9/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $27.00 -> $27.00 | High | View details for HC Wainwright rating of CleanSpark (NASDAQ:CLSK) on 9/25/2024 |
WVE Wave Life Sciences | $8.00
-0.5% | 9/25/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $15.00 -> $22.00 | High | View details for HC Wainwright rating of Wave Life Sciences (NASDAQ:WVE) on 9/25/2024 |
VALN Valneva | $5.84
-1.2% | 9/25/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $26.00 -> $23.00 | Low | View details for HC Wainwright rating of Valneva (NASDAQ:VALN) on 9/25/2024 |
ZYME Zymeworks | $12.53
+0.3% | 9/25/2024 | Target Raised by | HC Wainwright | - | Neutral -> Neutral | $10.00 -> $12.00 | Low | View details for HC Wainwright rating of Zymeworks (NYSE:ZYME) on 9/25/2024 |
CAPR Capricor Therapeutics | $19.33
+6.9% | 9/24/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $40.00 -> $40.00 | High | View details for HC Wainwright rating of Capricor Therapeutics (NASDAQ:CAPR) on 9/24/2024 |
[SHOCKING] Crypto Document Leak… (Ad) The crypto market waits for no one.
And my team of experts and I believe that a BIG move is right around the corner.
That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes. Download your digital copy now |
MOGO Mogo | $1.11
-0.9% | 9/24/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 -> $6.00 | Low | View details for HC Wainwright rating of Mogo (NASDAQ:MOGO) on 9/24/2024 |
UEC Uranium Energy | $6.87
+2.7% | 9/24/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.25 -> $10.25 | N/A | View details for HC Wainwright rating of Uranium Energy (NYSEAMERICAN:UEC) on 9/24/2024 |
ASMB Assembly Biosciences | $14.42
-2.0% | 9/24/2024 | Reiterated by | HC Wainwright | - | Neutral | | High | View details for HC Wainwright rating of Assembly Biosciences (NASDAQ:ASMB) on 9/24/2024 |
BHVN Biohaven | $53.56
+1.5% | 9/24/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $59.00 -> $59.00 | Medium | View details for HC Wainwright rating of Biohaven (NYSE:BHVN) on 9/24/2024 |
KOD Kodiak Sciences | $2.65
-0.4% | 9/24/2024 | Reiterated by | HC Wainwright | Analyst M. Caufield | Neutral -> Neutral | $3.00 -> $3.00 | Low | View details for HC Wainwright rating of Kodiak Sciences (NASDAQ:KOD) on 9/24/2024 |
BDTX Black Diamond Therapeutics | $3.56
-2.7% | 9/24/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 -> $11.00 | Medium | View details for HC Wainwright rating of Black Diamond Therapeutics (NASDAQ:BDTX) on 9/24/2024 |
BLCO Bausch + Lomb | $18.42
-1.9% | 9/23/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $19.00 -> $22.00 | Low | View details for HC Wainwright rating of Bausch + Lomb (NYSE:BLCO) on 9/23/2024 |
CNTX Context Therapeutics | $1.86
+1.6% | 9/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 -> $6.00 | High | View details for HC Wainwright rating of Context Therapeutics (NASDAQ:CNTX) on 9/23/2024 |
VTYX Ventyx Biosciences | $2.05
-3.3% | 9/23/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | $6.00 -> $6.00 | High | View details for HC Wainwright rating of Ventyx Biosciences (NASDAQ:VTYX) on 9/23/2024 |
BITF Bitfarms | $1.84
-2.6% | 9/23/2024 | Reiterated by | HC Wainwright | Analyst M. Colonnese | Buy -> Buy | $4.00 -> $4.00 | Low | View details for HC Wainwright rating of Bitfarms (NASDAQ:BITF) on 9/23/2024 |
CRBP Corbus Pharmaceuticals | $19.58
+3.1% | 9/23/2024 | Reiterated by | HC Wainwright | Analyst A. Maldonado | Buy -> Buy | $80.00 -> $80.00 | High | View details for HC Wainwright rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 9/23/2024 |
RPTX Repare Therapeutics | $3.45
| 9/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Repare Therapeutics (NASDAQ:RPTX) on 9/23/2024 |
GNFT Genfit | $5.59
+2.2% | 9/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $13.00 -> $13.00 | High | View details for HC Wainwright rating of Genfit (NASDAQ:GNFT) on 9/20/2024 |
XOMA XOMA | $27.45
+0.1% | 9/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $117.00 -> $117.00 | High | View details for HC Wainwright rating of XOMA (NASDAQ:XOMA) on 9/20/2024 |
ZVRA Zevra Therapeutics | $8.37
+7.4% | 9/20/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $18.00 -> $20.00 | High | View details for HC Wainwright rating of Zevra Therapeutics (NASDAQ:ZVRA) on 9/20/2024 |
DGHI Digihost Technology | $1.02
-4.7% | 9/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.50 -> $2.50 | High | View details for HC Wainwright rating of Digihost Technology (NASDAQ:DGHI) on 9/20/2024 |
LPTH LightPath Technologies | $1.49
+0.7% | 9/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 -> $3.00 | High | View details for HC Wainwright rating of LightPath Technologies (NASDAQ:LPTH) on 9/20/2024 |
GRYP Gryphon Digital Mining | $0.54
-5.2% | 9/20/2024 | Reiterated by | HC Wainwright | Analyst K. Dede | Neutral | | High | View details for HC Wainwright rating of Gryphon Digital Mining (NASDAQ:GRYP) on 9/20/2024 |
HUT Hut 8 | $11.34
-3.2% | 9/20/2024 | Reiterated by | HC Wainwright | Analyst M. Colonnese | Buy -> Buy | $13.50 -> $13.50 | Medium | View details for HC Wainwright rating of Hut 8 (NASDAQ:HUT) on 9/20/2024 |
ANGO AngioDynamics | $5.88
-3.6% | 9/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $14.00 -> $14.00 | High | View details for HC Wainwright rating of AngioDynamics (NASDAQ:ANGO) on 9/20/2024 |
EVAX Evaxion Biotech A/S | $2.84
-0.4% | 9/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $14.00 -> $14.00 | Low | View details for HC Wainwright rating of Evaxion Biotech A/S (NASDAQ:EVAX) on 9/20/2024 |
CYTK Cytokinetics | $54.33
-2.1% | 9/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $90.00 -> $90.00 | High | View details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 9/20/2024 |
GMAB Genmab A/S | $23.59
+0.7% | 9/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 -> $50.00 | High | View details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 9/20/2024 |
ALGS Aligos Therapeutics | $7.32
-2.4% | 9/20/2024 | Reiterated by | HC Wainwright | Analyst E. Arce | Buy -> Buy | $75.00 -> $75.00 | High | View details for HC Wainwright rating of Aligos Therapeutics (NASDAQ:ALGS) on 9/20/2024 |
PRLD Prelude Therapeutics | $2.04
+3.0% | 9/19/2024 | Upgraded by | HC Wainwright | Analyst R. Burns | Hold -> Strong-Buy | | Low | View details for HC Wainwright rating of Prelude Therapeutics (NASDAQ:PRLD) on 9/19/2024 |
BCT BriaCell Therapeutics | C$10.60
-3.8% | 9/19/2024 | Target Lowered by | HC Wainwright | - | | C$18.00 -> C$15.00 | N/A | View details for HC Wainwright rating of BriaCell Therapeutics (CVE:BCT) on 9/19/2024 |
ONCY Oncolytics Biotech | $1.27
-9.3% | 9/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 -> $5.00 | Low | View details for HC Wainwright rating of Oncolytics Biotech (NASDAQ:ONCY) on 9/19/2024 |
ACET Adicet Bio | $1.43
+1.4% | 9/19/2024 | Reiterated by | HC Wainwright | Analyst E. White | Neutral | | Medium | View details for HC Wainwright rating of Adicet Bio (NASDAQ:ACET) on 9/19/2024 |
NR Newpark Resources | $6.98
-2.1% | 9/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | Medium | View details for HC Wainwright rating of Newpark Resources (NYSE:NR) on 9/19/2024 |
FDMT 4D Molecular Therapeutics | $9.38
+1.3% | 9/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $36.00 -> $36.00 | High | View details for HC Wainwright rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 9/19/2024 |
ROIV Roivant Sciences | $11.28
+0.6% | 9/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 -> $18.00 | High | View details for HC Wainwright rating of Roivant Sciences (NASDAQ:ROIV) on 9/19/2024 |
BCTX BriaCell Therapeutics | $1.08
+0.9% | 9/19/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $18.00 -> $15.00 | High | View details for HC Wainwright rating of BriaCell Therapeutics (NASDAQ:BCTX) on 9/19/2024 |
KYTX Kyverna Therapeutics | $4.60
+3.4% | 9/19/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Neutral -> Neutral | $7.00 -> $7.00 | High | View details for HC Wainwright rating of Kyverna Therapeutics (NASDAQ:KYTX) on 9/19/2024 |
ORIC ORIC Pharmaceuticals | $9.49
-0.1% | 9/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $21.00 -> $21.00 | Low | View details for HC Wainwright rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 9/18/2024 |
TGTX TG Therapeutics | $21.84
+2.5% | 9/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $49.00 -> $49.00 | Low | View details for HC Wainwright rating of TG Therapeutics (NASDAQ:TGTX) on 9/18/2024 |
ADAG Adagene | $2.19
-1.8% | 9/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 -> $5.00 | High | View details for HC Wainwright rating of Adagene (NASDAQ:ADAG) on 9/18/2024 |
SOUN SoundHound AI | $4.68
-1.3% | 9/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of SoundHound AI (NASDAQ:SOUN) on 9/18/2024 |
LBPH Longboard Pharmaceuticals | $33.63
+0.8% | 9/18/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $60.00 -> $80.00 | High | View details for HC Wainwright rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 9/18/2024 |
LSTA Lisata Therapeutics | $2.99
| 9/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 -> $15.00 | High | View details for HC Wainwright rating of Lisata Therapeutics (NASDAQ:LSTA) on 9/18/2024 |
ACIU AC Immune | $3.31
-2.6% | 9/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 -> $16.00 | High | View details for HC Wainwright rating of AC Immune (NASDAQ:ACIU) on 9/18/2024 |
BDTX Black Diamond Therapeutics | $3.56
-2.7% | 9/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 -> $11.00 | High | View details for HC Wainwright rating of Black Diamond Therapeutics (NASDAQ:BDTX) on 9/18/2024 |
ZYME Zymeworks | $12.53
+0.3% | 9/18/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Zymeworks (NYSE:ZYME) on 9/18/2024 |
RYTM Rhythm Pharmaceuticals | $48.09
+1.9% | 9/18/2024 | Initiated by | HC Wainwright | Analyst R. Selvaraju | Buy | $64.00 | Low | View details for HC Wainwright rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 9/18/2024 |
EXEL Exelixis | $25.39
-3.5% | 9/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $29.00 -> $29.00 | High | View details for HC Wainwright rating of Exelixis (NASDAQ:EXEL) on 9/18/2024 |
MGNX MacroGenics | $3.62
+0.8% | 9/18/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | $4.00 -> $4.00 | Medium | View details for HC Wainwright rating of MacroGenics (NASDAQ:MGNX) on 9/18/2024 |
CAPR Capricor Therapeutics | $19.33
+6.9% | 9/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $40.00 -> $40.00 | Medium | View details for HC Wainwright rating of Capricor Therapeutics (NASDAQ:CAPR) on 9/17/2024 |
GOSS Gossamer Bio | $1.02
-2.9% | 9/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.00 | Medium | View details for HC Wainwright rating of Gossamer Bio (NASDAQ:GOSS) on 9/17/2024 |
VRNA Verona Pharma | $31.77
-0.9% | 9/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $36.00 -> $36.00 | Low | View details for HC Wainwright rating of Verona Pharma (NASDAQ:VRNA) on 9/17/2024 |
ACRS Aclaris Therapeutics | $1.16
+0.9% | 9/17/2024 | Reiterated by | HC Wainwright | - | Neutral | | Medium | View details for HC Wainwright rating of Aclaris Therapeutics (NASDAQ:ACRS) on 9/17/2024 |
ANIX Anixa Biosciences | $3.08
-1.6% | 9/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of Anixa Biosciences (NASDAQ:ANIX) on 9/17/2024 |
[SHOCKING] Crypto Document Leak… (Ad) The crypto market waits for no one.
And my team of experts and I believe that a BIG move is right around the corner.
That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes. Download your digital copy now |
AKRO Akero Therapeutics | $28.15
+5.2% | 9/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 -> $50.00 | Medium | View details for HC Wainwright rating of Akero Therapeutics (NASDAQ:AKRO) on 9/17/2024 |
IMCR Immunocore | $30.57
-0.6% | 9/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $100.00 -> $100.00 | Low | View details for HC Wainwright rating of Immunocore (NASDAQ:IMCR) on 9/17/2024 |
RICK RCI Hospitality | $41.50
+0.3% | 9/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $98.00 -> $98.00 | Medium | View details for HC Wainwright rating of RCI Hospitality (NASDAQ:RICK) on 9/17/2024 |
WRN Western Copper & Gold | $1.21
-2.4% | 9/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.25 -> $4.25 | Low | View details for HC Wainwright rating of Western Copper & Gold (NYSE:WRN) on 9/17/2024 |
UROY Uranium Royalty | $2.60
| 9/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.70 -> $7.70 | Low | View details for HC Wainwright rating of Uranium Royalty (NASDAQ:UROY) on 9/17/2024 |
ANIP ANI Pharmaceuticals | $56.79
+1.7% | 9/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $94.00 -> $94.00 | High | View details for HC Wainwright rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 9/17/2024 |
PDSB PDS Biotechnology | $3.56
-4.6% | 9/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $21.00 -> $21.00 | Low | View details for HC Wainwright rating of PDS Biotechnology (NASDAQ:PDSB) on 9/17/2024 |
CGON CG Oncology | $34.82
-1.9% | 9/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $75.00 -> $75.00 | Medium | View details for HC Wainwright rating of CG Oncology (NASDAQ:CGON) on 9/17/2024 |
KRRO Korro Bio | $35.01
-2.4% | 9/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $100.00 -> $100.00 | High | View details for HC Wainwright rating of Korro Bio (NASDAQ:KRRO) on 9/17/2024 |
OPK OPKO Health | $1.47
+1.4% | 9/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 -> $3.00 | Medium | View details for HC Wainwright rating of OPKO Health (NASDAQ:OPK) on 9/17/2024 |
IMAB I-Mab | $1.36
-8.1% | 9/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 -> $8.00 | Medium | View details for HC Wainwright rating of I-Mab (NASDAQ:IMAB) on 9/17/2024 |
CABA Cabaletta Bio | $4.34
+8.2% | 9/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $25.00 -> $25.00 | High | View details for HC Wainwright rating of Cabaletta Bio (NASDAQ:CABA) on 9/17/2024 |
IPA ImmunoPrecise Antibodies | $0.63
+1.6% | 9/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 -> $9.00 | Medium | View details for HC Wainwright rating of ImmunoPrecise Antibodies (NASDAQ:IPA) on 9/17/2024 |
BWAY BrainsWay | $9.46
+0.7% | 9/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 -> $16.00 | Low | View details for HC Wainwright rating of BrainsWay (NASDAQ:BWAY) on 9/16/2024 |
CKPT Checkpoint Therapeutics | $2.37
-2.9% | 9/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 -> $20.00 | High | View details for HC Wainwright rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 9/16/2024 |
CLNN Clene | $5.13
-3.6% | 9/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $31.00 -> $31.00 | Medium | View details for HC Wainwright rating of Clene (NASDAQ:CLNN) on 9/16/2024 |
CGEM Cullinan Therapeutics | $16.11
+0.4% | 9/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $28.00 -> $28.00 | High | View details for HC Wainwright rating of Cullinan Therapeutics (NASDAQ:CGEM) on 9/16/2024 |
CDTX Cidara Therapeutics | $10.71
-3.8% | 9/16/2024 | Reiterated by | HC Wainwright | Analyst E. Arce | Buy -> Buy | $24.00 -> $24.00 | Low | View details for HC Wainwright rating of Cidara Therapeutics (NASDAQ:CDTX) on 9/16/2024 |
COYA Coya Therapeutics | $7.00
-2.0% | 9/16/2024 | Initiated by | HC Wainwright | Analyst R. Selvaraju | Buy | $18.00 | High | View details for HC Wainwright rating of Coya Therapeutics (NASDAQ:COYA) on 9/16/2024 |
STRO Sutro Biopharma | $3.52
-0.8% | 9/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | High | View details for HC Wainwright rating of Sutro Biopharma (NASDAQ:STRO) on 9/16/2024 |
BBIO BridgeBio Pharma | $24.73
-0.4% | 9/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $43.00 -> $43.00 | Medium | View details for HC Wainwright rating of BridgeBio Pharma (NASDAQ:BBIO) on 9/16/2024 |
SMMT Summit Therapeutics | $19.69
+4.1% | 9/16/2024 | Target Raised by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $30.00 -> $45.00 | High | View details for HC Wainwright rating of Summit Therapeutics (NASDAQ:SMMT) on 9/16/2024 |
REPL Replimune Group | $11.74
+3.6% | 9/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.00 -> $17.00 | High | View details for HC Wainwright rating of Replimune Group (NASDAQ:REPL) on 9/16/2024 |
NUVB Nuvation Bio | $2.23
+2.8% | 9/16/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $8.00 -> $7.00 | Low | View details for HC Wainwright rating of Nuvation Bio (NYSE:NUVB) on 9/16/2024 |
PRLD Prelude Therapeutics | $2.04
+3.0% | 9/16/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | $5.00 -> $5.00 | High | View details for HC Wainwright rating of Prelude Therapeutics (NASDAQ:PRLD) on 9/16/2024 |
RLAY Relay Therapeutics | $6.25
-1.4% | 9/16/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $18.00 -> $19.00 | Low | View details for HC Wainwright rating of Relay Therapeutics (NASDAQ:RLAY) on 9/16/2024 |
ACRV Acrivon Therapeutics | $7.00
+0.9% | 9/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $22.00 -> $22.00 | High | View details for HC Wainwright rating of Acrivon Therapeutics (NASDAQ:ACRV) on 9/16/2024 |
IOBT IO Biotech | $1.15
+7.5% | 9/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | High | View details for HC Wainwright rating of IO Biotech (NASDAQ:IOBT) on 9/16/2024 |
BNTX BioNTech | $120.30
-1.0% | 9/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $113.00 -> $113.00 | Low | View details for HC Wainwright rating of BioNTech (NASDAQ:BNTX) on 9/16/2024 |
CNTX Context Therapeutics | $1.86
+1.6% | 9/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 -> $6.00 | Medium | View details for HC Wainwright rating of Context Therapeutics (NASDAQ:CNTX) on 9/16/2024 |
ITOS iTeos Therapeutics | $9.43
-3.8% | 9/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $46.00 -> $46.00 | High | View details for HC Wainwright rating of iTeos Therapeutics (NASDAQ:ITOS) on 9/16/2024 |
BCYC Bicycle Therapeutics | $23.53
+0.6% | 9/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $55.00 -> $55.00 | High | View details for HC Wainwright rating of Bicycle Therapeutics (NASDAQ:BCYC) on 9/16/2024 |
IRON Disc Medicine | $47.90
+1.2% | 9/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $70.00 -> $70.00 | Low | View details for HC Wainwright rating of Disc Medicine (NASDAQ:IRON) on 9/16/2024 |
TBPH Theravance Biopharma | $7.93
-1.5% | 9/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 -> $15.00 | Low | View details for HC Wainwright rating of Theravance Biopharma (NASDAQ:TBPH) on 9/16/2024 |
CHRS Coherus BioSciences | $1.04
-2.8% | 9/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | High | View details for HC Wainwright rating of Coherus BioSciences (NASDAQ:CHRS) on 9/16/2024 |
SXTP 60 Degrees Pharmaceuticals | $1.04
+1.0% | 9/13/2024 | Reiterated by | HC Wainwright | - | Neutral | | High | View details for HC Wainwright rating of 60 Degrees Pharmaceuticals (NASDAQ:SXTP) on 9/13/2024 |
GEVO Gevo | $1.79
-2.7% | 9/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $14.00 -> $14.00 | High | View details for HC Wainwright rating of Gevo (NASDAQ:GEVO) on 9/13/2024 |
IPHA Innate Pharma | $2.14
+3.9% | 9/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.50 -> $11.50 | Low | View details for HC Wainwright rating of Innate Pharma (NASDAQ:IPHA) on 9/13/2024 |
AURA Aura Biosciences | $8.45
+0.2% | 9/13/2024 | Reiterated by | HC Wainwright | Analyst E. White | Buy -> Buy | $21.00 -> $21.00 | High | View details for HC Wainwright rating of Aura Biosciences (NASDAQ:AURA) on 9/13/2024 |
RNAC Cartesian Therapeutics | $24.12
+6.2% | 9/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $45.00 -> $45.00 | Medium | View details for HC Wainwright rating of Cartesian Therapeutics (NASDAQ:RNAC) on 9/13/2024 |
CTMX CytomX Therapeutics | $1.14
-2.6% | 9/13/2024 | Reiterated by | HC Wainwright | - | Neutral | | Medium | View details for HC Wainwright rating of CytomX Therapeutics (NASDAQ:CTMX) on 9/13/2024 |
HALO Halozyme Therapeutics | $54.13
+0.5% | 9/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $65.00 -> $65.00 | Medium | View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 9/13/2024 |
PLRX Pliant Therapeutics | $11.24
+1.1% | 9/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $38.00 -> $38.00 | High | View details for HC Wainwright rating of Pliant Therapeutics (NASDAQ:PLRX) on 9/13/2024 |
GMAB Genmab A/S | $23.59
+0.7% | 9/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 -> $50.00 | Medium | View details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 9/13/2024 |
FULC Fulcrum Therapeutics | $3.54
-0.8% | 9/13/2024 | Downgraded by | HC Wainwright | Analyst A. Fein | Buy -> Neutral | $17.00 -> $4.00 | High | View details for HC Wainwright rating of Fulcrum Therapeutics (NASDAQ:FULC) on 9/13/2024 |
ICCM IceCure Medical | $0.59
| 9/12/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.50 -> $2.50 | High | View details for HC Wainwright rating of IceCure Medical (NASDAQ:ICCM) on 9/12/2024 |
VYNE VYNE Therapeutics | $1.82
-2.2% | 9/12/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.75 -> $5.75 | High | View details for HC Wainwright rating of VYNE Therapeutics (NASDAQ:VYNE) on 9/12/2024 |
PTGX Protagonist Therapeutics | $43.96
+0.4% | 9/12/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $40.00 -> $50.00 | Medium | View details for HC Wainwright rating of Protagonist Therapeutics (NASDAQ:PTGX) on 9/12/2024 |
FEMY Femasys | $1.13
+3.7% | 9/12/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | Medium | View details for HC Wainwright rating of Femasys (NASDAQ:FEMY) on 9/12/2024 |
TIL Instil Bio | $35.60
-10.9% | 9/12/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $25.00 -> $40.00 | N/A | View details for HC Wainwright rating of Instil Bio (NASDAQ:TIL) on 9/12/2024 |
[SHOCKING] Crypto Document Leak… (Ad) The crypto market waits for no one.
And my team of experts and I believe that a BIG move is right around the corner.
That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes. Download your digital copy now |
MLTX MoonLake Immunotherapeutics | $49.85
-3.7% | 9/12/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $100.00 -> $100.00 | High | View details for HC Wainwright rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 9/12/2024 |
BLTE Belite Bio | $53.92
+5.9% | 9/12/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $60.00 -> $60.00 | Low | View details for HC Wainwright rating of Belite Bio (NASDAQ:BLTE) on 9/12/2024 |
BCTX BriaCell Therapeutics | $1.08
+0.9% | 9/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 -> $18.00 | High | View details for HC Wainwright rating of BriaCell Therapeutics (NASDAQ:BCTX) on 9/11/2024 |
CLSK CleanSpark | $9.00
-1.1% | 9/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $27.00 -> $27.00 | Low | View details for HC Wainwright rating of CleanSpark (NASDAQ:CLSK) on 9/11/2024 |
STOK Stoke Therapeutics | $12.28
+7.7% | 9/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $35.00 -> $35.00 | High | View details for HC Wainwright rating of Stoke Therapeutics (NASDAQ:STOK) on 9/11/2024 |
LXRX Lexicon Pharmaceuticals | $1.68
| 9/11/2024 | Reiterated by | HC Wainwright | Analyst J. Pantginis | Buy -> Buy | $10.00 -> $10.00 | Low | View details for HC Wainwright rating of Lexicon Pharmaceuticals (NASDAQ:LXRX) on 9/11/2024 |
ROIV Roivant Sciences | $11.28
+0.6% | 9/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 -> $18.00 | Low | View details for HC Wainwright rating of Roivant Sciences (NASDAQ:ROIV) on 9/11/2024 |
RMTI Rockwell Medical | $3.40
-6.9% | 9/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 -> $9.00 | High | View details for HC Wainwright rating of Rockwell Medical (NASDAQ:RMTI) on 9/11/2024 |
VRNA Verona Pharma | $31.77
-0.9% | 9/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $36.00 -> $36.00 | High | View details for HC Wainwright rating of Verona Pharma (NASDAQ:VRNA) on 9/11/2024 |
ACET Adicet Bio | $1.43
+1.4% | 9/11/2024 | Downgraded by | HC Wainwright | Analyst E. White | Buy -> Neutral | | Medium | View details for HC Wainwright rating of Adicet Bio (NASDAQ:ACET) on 9/11/2024 |
VRDN Viridian Therapeutics | $23.40
+0.6% | 9/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $27.00 -> $27.00 | High | View details for HC Wainwright rating of Viridian Therapeutics (NASDAQ:VRDN) on 9/10/2024 |
ITRM Iterum Therapeutics | $0.96
-2.0% | 9/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 -> $5.00 | High | View details for HC Wainwright rating of Iterum Therapeutics (NASDAQ:ITRM) on 9/10/2024 |
REPL Replimune Group | $11.74
+3.6% | 9/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.00 -> $17.00 | Medium | View details for HC Wainwright rating of Replimune Group (NASDAQ:REPL) on 9/10/2024 |
TNGX Tango Therapeutics | $6.89
-1.4% | 9/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $13.00 -> $13.00 | Medium | View details for HC Wainwright rating of Tango Therapeutics (NASDAQ:TNGX) on 9/10/2024 |
AVBP ArriVent BioPharma | $27.39
-0.2% | 9/10/2024 | Target Raised by | HC Wainwright | Analyst R. Burns | Buy -> Buy | $30.00 -> $36.00 | High | View details for HC Wainwright rating of ArriVent BioPharma (NASDAQ:AVBP) on 9/10/2024 |
IMVT Immunovant | $29.61
+0.7% | 9/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $51.00 -> $51.00 | High | View details for HC Wainwright rating of Immunovant (NASDAQ:IMVT) on 9/10/2024 |
PRAX Praxis Precision Medicines | $64.77
+3.6% | 9/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $120.00 -> $120.00 | Low | View details for HC Wainwright rating of Praxis Precision Medicines (NASDAQ:PRAX) on 9/10/2024 |
PRLD Prelude Therapeutics | $2.04
+3.0% | 9/10/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | $5.00 -> $5.00 | High | View details for HC Wainwright rating of Prelude Therapeutics (NASDAQ:PRLD) on 9/10/2024 |
RZLT Rezolute | $4.78
| 9/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $14.00 -> $14.00 | High | View details for HC Wainwright rating of Rezolute (NASDAQ:RZLT) on 9/9/2024 |
ORMP Oramed Pharmaceuticals | $2.33
-3.3% | 9/9/2024 | Reiterated by | HC Wainwright | - | Neutral | | Medium | View details for HC Wainwright rating of Oramed Pharmaceuticals (NASDAQ:ORMP) on 9/9/2024 |
CYTK Cytokinetics | $54.33
-2.1% | 9/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $90.00 -> $90.00 | Medium | View details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 9/9/2024 |
ENLV Enlivex Therapeutics | $1.50
-2.0% | 9/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 -> $6.00 | High | View details for HC Wainwright rating of Enlivex Therapeutics (NASDAQ:ENLV) on 9/9/2024 |
SMMT Summit Therapeutics | $19.69
+4.1% | 9/9/2024 | Target Raised by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $16.00 -> $30.00 | High | View details for HC Wainwright rating of Summit Therapeutics (NASDAQ:SMMT) on 9/9/2024 |
ELVN Enliven Therapeutics | $28.01
+2.0% | 9/9/2024 | Initiated by | HC Wainwright | Analyst R. Burns | Buy | $37.00 | High | View details for HC Wainwright rating of Enliven Therapeutics (NASDAQ:ELVN) on 9/9/2024 |
DPRO Draganfly | $3.47
+7.1% | 9/6/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $0.50 -> $7.00 | Low | View details for HC Wainwright rating of Draganfly (NASDAQ:DPRO) on 9/6/2024 |
AUPH Aurinia Pharmaceuticals | $6.82
-0.3% | 9/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $13.00 -> $13.00 | Low | View details for HC Wainwright rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 9/6/2024 |
AG First Majestic Silver | $6.29
+1.3% | 9/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.50 -> $8.50 | Low | View details for HC Wainwright rating of First Majestic Silver (NYSE:AG) on 9/6/2024 |
MGX Metagenomi | $2.01
+0.5% | 9/6/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $7.00 -> $7.00 | Low | View details for HC Wainwright rating of Metagenomi (NASDAQ:MGX) on 9/6/2024 |
AFMD Affimed | $3.14
-0.6% | 9/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.00 | Low | View details for HC Wainwright rating of Affimed (NASDAQ:AFMD) on 9/6/2024 |
VOR Vor Biopharma | $0.68
-1.4% | 9/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.50 -> $17.50 | Low | View details for HC Wainwright rating of Vor Biopharma (NYSE:VOR) on 9/6/2024 |
TVTX Travere Therapeutics | $15.21
-0.3% | 9/6/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $20.00 -> $23.00 | Low | View details for HC Wainwright rating of Travere Therapeutics (NASDAQ:TVTX) on 9/6/2024 |
AKBA Akebia Therapeutics | $1.32
| 9/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.50 -> $7.50 | Low | View details for HC Wainwright rating of Akebia Therapeutics (NASDAQ:AKBA) on 9/6/2024 |
CNTB Connect Biopharma | $1.28
+1.6% | 9/6/2024 | Reiterated by | HC Wainwright | Analyst E. Bodnar | Buy -> Buy | $8.00 -> $8.00 | Low | View details for HC Wainwright rating of Connect Biopharma (NASDAQ:CNTB) on 9/6/2024 |
BTAI BioXcel Therapeutics | $0.56
+1.8% | 9/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | Low | View details for HC Wainwright rating of BioXcel Therapeutics (NASDAQ:BTAI) on 9/6/2024 |
KALV KalVista Pharmaceuticals | $11.21
-0.6% | 9/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 -> $20.00 | Low | View details for HC Wainwright rating of KalVista Pharmaceuticals (NASDAQ:KALV) on 9/6/2024 |
GHRS GH Research | $6.44
+2.2% | 9/5/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $40.00 -> $40.00 | Low | View details for HC Wainwright rating of GH Research (NASDAQ:GHRS) on 9/5/2024 |
COLL Collegium Pharmaceutical | $38.02
-4.5% | 9/5/2024 | Target Raised by | HC Wainwright | Analyst O. Livnat | Buy -> Buy | $47.00 -> $50.00 | Low | View details for HC Wainwright rating of Collegium Pharmaceutical (NASDAQ:COLL) on 9/5/2024 |
USAU U.S. Gold | $5.57
-2.1% | 9/5/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 -> $11.00 | Low | View details for HC Wainwright rating of U.S. Gold (NASDAQ:USAU) on 9/5/2024 |
ZURA Zura Bio | $4.21
-1.2% | 9/5/2024 | Initiated by | HC Wainwright | Analyst M. Kapoor | Neutral | $5.00 | Low | View details for HC Wainwright rating of Zura Bio (NASDAQ:ZURA) on 9/5/2024 |
IGMS IGM Biosciences | $14.55
+6.0% | 9/5/2024 | Target Lowered by | HC Wainwright | - | Neutral -> Neutral | $12.00 -> $11.00 | Low | View details for HC Wainwright rating of IGM Biosciences (NASDAQ:IGMS) on 9/5/2024 |
AXSM Axsome Therapeutics | $84.82
+0.8% | 9/5/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $180.00 -> $180.00 | Low | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 9/5/2024 |
KOD Kodiak Sciences | $2.65
-0.4% | 9/5/2024 | Initiated by | HC Wainwright | Analyst M. Caufield | Neutral | $3.00 | Low | View details for HC Wainwright rating of Kodiak Sciences (NASDAQ:KOD) on 9/5/2024 |
RGNX REGENXBIO | $9.56
+0.4% | 9/4/2024 | Reiterated by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $39.00 -> $39.00 | Low | View details for HC Wainwright rating of REGENXBIO (NASDAQ:RGNX) on 9/4/2024 |
ZYXI Zynex | $7.74
-0.5% | 9/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 -> $16.00 | Low | View details for HC Wainwright rating of Zynex (NASDAQ:ZYXI) on 9/4/2024 |
NMG Nouveau Monde Graphite | $1.50
-3.8% | 9/4/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $3.25 -> $3.00 | Low | View details for HC Wainwright rating of Nouveau Monde Graphite (NYSE:NMG) on 9/4/2024 |
ETON Eton Pharmaceuticals | $7.40
+1.4% | 9/4/2024 | Reiterated by | HC Wainwright | - | Buy | $9.00 | Low | View details for HC Wainwright rating of Eton Pharmaceuticals (NASDAQ:ETON) on 9/4/2024 |
LGVN Longeveron | $1.84
+1.1% | 9/4/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $10.00 -> $10.00 | Low | View details for HC Wainwright rating of Longeveron (NASDAQ:LGVN) on 9/4/2024 |
RMTI Rockwell Medical | $3.40
-6.9% | 9/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 -> $9.00 | Low | View details for HC Wainwright rating of Rockwell Medical (NASDAQ:RMTI) on 9/4/2024 |
RNAC Cartesian Therapeutics | $24.12
+6.2% | 9/4/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $45.00 -> $45.00 | Low | View details for HC Wainwright rating of Cartesian Therapeutics (NASDAQ:RNAC) on 9/4/2024 |
RPTX Repare Therapeutics | $3.45
| 9/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.00 | Low | View details for HC Wainwright rating of Repare Therapeutics (NASDAQ:RPTX) on 9/4/2024 |
BDTX Black Diamond Therapeutics | $3.56
-2.7% | 9/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 -> $11.00 | Low | View details for HC Wainwright rating of Black Diamond Therapeutics (NASDAQ:BDTX) on 9/4/2024 |
DYN Dyne Therapeutics | $33.13
+4.6% | 9/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $55.00 -> $55.00 | Low | View details for HC Wainwright rating of Dyne Therapeutics (NASDAQ:DYN) on 9/4/2024 |
DNLI Denali Therapeutics | $26.73
+0.5% | 9/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $90.00 -> $90.00 | Low | View details for HC Wainwright rating of Denali Therapeutics (NASDAQ:DNLI) on 9/4/2024 |
ANL Adlai Nortye | $1.97
+1.5% | 9/4/2024 | Initiated by | HC Wainwright | Analyst J. Pantginis | Buy | $9.00 | Low | View details for HC Wainwright rating of Adlai Nortye (NASDAQ:ANL) on 9/4/2024 |
ARWR Arrowhead Pharmaceuticals | $18.02
-0.6% | 9/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $60.00 -> $60.00 | Low | View details for HC Wainwright rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 9/3/2024 |
PRAX Praxis Precision Medicines | $64.77
+3.6% | 9/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $120.00 -> $120.00 | Low | View details for HC Wainwright rating of Praxis Precision Medicines (NASDAQ:PRAX) on 9/3/2024 |
LXRX Lexicon Pharmaceuticals | $1.68
| 9/3/2024 | Reiterated by | HC Wainwright | Analyst J. Pantginis | Buy -> Buy | $10.00 -> $10.00 | Low | View details for HC Wainwright rating of Lexicon Pharmaceuticals (NASDAQ:LXRX) on 9/3/2024 |
CYTK Cytokinetics | $54.33
-2.1% | 9/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $90.00 -> $90.00 | Low | View details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 9/3/2024 |
IVVD Invivyd | $0.91
-1.1% | 9/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 -> $15.00 | Low | View details for HC Wainwright rating of Invivyd (NASDAQ:IVVD) on 9/3/2024 |
CRBU Caribou Biosciences | $1.89
+3.8% | 9/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 -> $9.00 | Low | View details for HC Wainwright rating of Caribou Biosciences (NASDAQ:CRBU) on 9/3/2024 |
